Abstract:Introduction and Objective: Metabolic syndrome (MetS) in obesity increases the risk for type 2 diabetes, stroke, and heart disease. Fundamental gaps in the field remain to establish specific molecular targets to counteract MetS. Transglutaminase 2 (TGM2), a multifunctional enzyme known to crosslink proteins important for GTPase, cell adhesion, and scaffold activities has been implicated in adipose tissue growth and functioning. The objective of this study was to investigate TGM2 effects in MetS in a diet-induced obese mouse model. Methods: C57BL/6 mice were placed on HFD for 10 weeks and silenced for TGM2 via in vivo RNAi silencing or received a scramble sequence control. Readout indices to evaluate MetS included glucose and insulin tolerance tests, body weight and food consumption monitoring, body DEXA scan, excised tissue phenotyping via histology, qPCR, RNAseq and western blot. Serum was assessed for adiponectin, leptin, free fatty acids and inflammatory parameters. Results: Successful TGM2 silencing was found predominantly in epididymal white adipose tissue (eWAT) and liver. Diet-induced obese mice silenced for TGM2 had lower total body weight that was accompanied with improved glucose sensitivity, lower serum leptin and free fatty acid concentrations, reduced mean adipocyte size and increased adipocyte number in eWAT, along with reduced expression of molecular pathways associated with adipose tissue growth. Furthermore, there was an observed reduction in liver weight and hepatic steatosis and increased total lean mass. Conclusion: Results suggest that reducing TGM2 expression reduced obesity and improved glucose homeostasis, making TGM2 modulation in obesity a promising therapeutic approach targeting MetS. Disclosure D. Elizondo: None. M. Hollis: None. T.P. Patel: None. R. Roberson: None. J. Chen: None. J.A. Yanovski: Research Support; Rhythm Pharmaceuticals, Inc., Soleno Pharmaceuticals, Inc, Versanis Bil, Hikma Pharmaceuticals, Inc., National Institutes of Health. Funding National Institute of Child Health and Human Development (ZIAHD00641); National Institute of Diabetes and Digestive and Kidney Diseases (1K99DK136921)

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

The Effects of New Selective PPARα Agonist CP775146 on Systematic Lipid Metabolism in Obese Mice and Its Potential Mechanism.

Dietary control of peripheral adipose storage capacity through membrane lipid remodelling

Hepatic CPT1A Facilitates Liver–Adipose Cross Talk via Induction of FGF21 in Mice

Ablation of PPP1R3G Reduces Glycogen Deposition and Mitigates High-Fat Diet Induced Obesity.

Glycophagy mediated glucose-induced changes of hepatic glycogen metabolism via OGT1-AKT1-FOXO1 Ser238 pathway

Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure

mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b

Mice lacking triglyceride synthesis enzymes in adipose tissue are resistant to diet-induced obesity

Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice

Adipocyte LDL receptor–related protein–1 expression modulates postprandial lipid transport and glucose homeostasis in mice

Enhanced Susceptibility of Cpt1c Knockout Mice to Glucose Intolerance Induced by a High-Fat Diet Involves Elevated Hepatic Gluconeogenesis and Decreased Skeletal Muscle Glucose Uptake.

1656-P: In Vivo Downregulation of Transglutaminase 2 in High Fat Diet (HFD)-Induced Obese Mice Reduces Metabolic Syndrome–Associated Factors

Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity

Enhanced C/EBPβ function promotes hypertrophic versus hyperplastic fat tissue growth and prevents steatosis in response to high-fat diet feeding

Hepatic glucuronyl C5-epimerase combats obesity by stabilising GDF15

Hepatic Gadd45β Promotes Hyperglycemia and Glucose Intolerance Through DNA Demethylation of PGC-1α

Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b

2047-LB: METTL2 Knockout Mitigates Obesity and Metabolic Disorders Induced by High-Fat Diet

Lipid-induced Muscle Insulin Resistance is Mediated by GGPPS Via Modulation of the RhoA/Rho Kinase Signaling Pathway*